Advertisement
Home Tags Obesity

Tag: Obesity

Post-Kidney Transplant Adverse Outcomes Increased With BMI-BSA Obesity

0

Risks were significantly greater than when body mass index and body surface area were discordant

Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills

0
By I. Edwards HealthDay Reporter FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop...

Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery

0

Findings for matched groups of patients with obesity and diabetes taking first-generation GLP-1 RA or undergoing bariatric metabolic surgery

Metabolic and Bariatric Surgery Increased in Adolescents From 2021 to 2023

0

Findings seen despite a downward trend in adults and the approval of second-generation antiobesity medications

GLP-1 Receptor Agonists Reduce Alcohol Intake in Patients Treated for Obesity

0

Reductions in alcohol intake noted in high and low consumers; no significant difference seen in percentage reductions for men and women

Hyperglycemia, Insulin Resistance in Teens Linked to Worsening Cardiac Damage at Age 24

0

Persistent hyperglycemia linked to increased odds of worsening left ventricular hypertrophy over seven years

Metformin Beneficial for Osteoarthritis Knee Pain in Overweight, Obesity

0

Mean change in visual analog scale pain greater with metformin versus placebo for patients with symptomatic knee osteoarthritis

Metabolic Syndrome Linked to Increased Risk for Young-Onset Dementia

0

Risk for young-onset dementia, Alzheimer disease, and vascular dementia increased in association with MetS

Adverse Pregnancy Outcomes Partly Mediate Association Between Prepregnancy Obesity, CVD Risk

0

Gestational diabetes mellitus mediated 24.6 percent of the association between obesity and hemoglobin A1c

Pfizer Ends Testing of Obesity Pill After Possible Liver Injury

0
By I. Edwards HealthDay Reporter TUESDAY, April 15, 2025 (HealthDay News) -- Pfizer has stopped developing a once-daily pill to treat obesity after a person...